MBQ Pharma
Company

MBQ Pharma

Pharmaceutical Manufacturing San Juan, Pr 4 employees
Employees
4

MBQ Pharma Overview

Headquarters
San Juan, Pr
Website
mbqpharma.com
Industry
Pharmaceutical Manufacturing
Employees
4
Founded
2018
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About MBQ Pharma

MBQ-Pharma targets Rac and CDC42 as key targets for tumor growth inhibition and removal of pre-existing metastasis. MBQ-167 is a first-in-class nanomolar IC50 inhibitor for Rac and CDC42 and has been shown in mouse tumor models to inhibit tumor growth and to reverse advanced metastasis. MBQ-167 has also been shown to have no toxicity findings in rats and dogs through GLP studies and in Safety Pharmacology studies. The IND for MBQ-167 is scheduled by the end of 2021.

MBQ Pharma Contact Details

People in AeroLeads
1

MBQ Pharma Org Chart

Sample employees and titles
Name Title Contact
Suranganie Dharmawardhane Flanagan Chief Scientific Officer at Mbq Pharma
View

Compare Similar Companies to MBQ Pharma